» Articles » PMID: 36406254

From Liver Fibrosis to Hepatocarcinogenesis: Role of Excessive Liver HO and Targeting Nanotherapeutics

Overview
Journal Bioact Mater
Date 2022 Nov 21
PMID 36406254
Authors
Affiliations
Soon will be listed here.
Abstract

Liver fibrosis and hepatocellular carcinoma (HCC) have been worldwide threats nowadays. Liver fibrosis is reversible in early stages but will develop precancerosis of HCC in cirrhotic stage. In pathological liver, excessive HO is generated and accumulated, which impacts the functionality of hepatocytes, Kupffer cells (KCs) and hepatic stellate cells (HSCs), leading to genesis of fibrosis and HCC. HO accumulation is associated with overproduction of superoxide anion (O ) and abolished antioxidant enzyme systems. Plenty of therapeutics focused on HO have shown satisfactory effects against liver fibrosis or HCC in different ways. This review summarized the reasons of liver HO accumulation, and the role of HO in genesis of liver fibrosis and HCC. Additionally, nanotherapeutics targeting HO were summarized for further consideration of antifibrotic or antitumor therapy.

Citing Articles

Correlation Between Transient Elastography and Non-invasive Biomarker Scores for the Detection of Liver Fibrosis.

Asif M, Sohaib M, Anwaar W, Ahmed A, Khalid N, Tariq H Cureus. 2024; 16(11):e72892.

PMID: 39624533 PMC: 11611420. DOI: 10.7759/cureus.72892.


Liver-Targeted Nanoparticles Loaded with Cannabidiol Based on Redox Response for Effective Alleviation of Acute Liver Injury.

Zhang X, Yi X, Gao X, Li Y, Shen X Foods. 2024; 13(15).

PMID: 39123655 PMC: 11311329. DOI: 10.3390/foods13152464.


Voltammetric determination of hydrogen peroxide at decorated palladium nanoparticles/poly 1,5-diaminonaphthalene modified carbon-paste electrode.

Khalifa Z, Abo Oura M, Hathoot A, Azzem M R Soc Open Sci. 2024; 11(6):231894.

PMID: 39100189 PMC: 11296075. DOI: 10.1098/rsos.231894.


Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis.

Ojha U, Kim S, Rhee C, You J, Choi Y, Yoon S Hepatology. 2024; .

PMID: 39042837 PMC: 11902585. DOI: 10.1097/HEP.0000000000001018.


Smart Microneedle Arrays Integrating Cell-Free Therapy and Nanocatalysis to Treat Liver Fibrosis.

Xu Y, Zhang Y, Tian H, Zhong Q, Yi K, Li F Adv Sci (Weinh). 2024; 11(31):e2309940.

PMID: 38874114 PMC: 11336984. DOI: 10.1002/advs.202309940.


References
1.
Min Y, Caster J, Eblan M, Wang A . Clinical Translation of Nanomedicine. Chem Rev. 2015; 115(19):11147-90. PMC: 4607605. DOI: 10.1021/acs.chemrev.5b00116. View

2.
Yu Y, Sun X, Gu J, Yu C, Wen Y, Gao Y . Deficiency of DJ-1 Ameliorates Liver Fibrosis through Inhibition of Hepatic ROS Production and Inflammation. Int J Biol Sci. 2016; 12(10):1225-1235. PMC: 5069444. DOI: 10.7150/ijbs.15154. View

3.
Ganne-Carrie N, Nahon P . Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol. 2019; 70(2):284-293. DOI: 10.1016/j.jhep.2018.10.008. View

4.
Laurent A, Nicco C, Chereau C, Goulvestre C, Alexandre J, Alves A . Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res. 2005; 65(3):948-56. View

5.
Li Y, Chen M, Xu Y, Yu X, Xiong T, Du M . Iron-Mediated Lysosomal Membrane Permeabilization in Ethanol-Induced Hepatic Oxidative Damage and Apoptosis: Protective Effects of Quercetin. Oxid Med Cell Longev. 2016; 2016:4147610. PMC: 4707336. DOI: 10.1155/2016/4147610. View